PharmaResources (Shanghai) Co. Ltd. A (301230) - Total Liabilities

Latest as of June 2025: CN¥296.42 Million CNY ≈ $43.38 Million USD

Based on the latest financial reports, PharmaResources (Shanghai) Co. Ltd. A (301230) has total liabilities worth CN¥296.42 Million CNY (≈ $43.38 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 301230 cash flow conversion to assess how effectively this company generates cash.

PharmaResources (Shanghai) Co. Ltd. A - Total Liabilities Trend (2020–2024)

This chart illustrates how PharmaResources (Shanghai) Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Check 301230 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

PharmaResources (Shanghai) Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of PharmaResources (Shanghai) Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
Jiangsu Hanvo Safety Product Co. Ltd. SHE:300952	China	CN¥1.10 Billion
TotalEnergies EP Gabon S.A. PA:EC	France	€1.32 Billion
Shanghai Fengyuzhu Exhibition Co Ltd Class A SHG:603466	China	CN¥2.48 Billion
Cathay Real Estate Development Co Ltd TW:2501	Taiwan	NT$59.58 Billion
Bide Pharmatech Co. Ltd. A SHG:688073	China	CN¥581.46 Million
Inspur Software Co Ltd SHG:600756	China	CN¥2.03 Billion
Benakat Petroleum Energy JK:BIPI	Indonesia	Rp1.05 Billion
Aditya Birla Fashion and Retail Limited NSE:ABFRL	India	Rs109.51 Billion

Liability Composition Analysis (2020–2024)

This chart breaks down PharmaResources (Shanghai) Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PharmaResources (Shanghai) Co. Ltd. A (301230) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.14	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.22	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PharmaResources (Shanghai) Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PharmaResources (Shanghai) Co. Ltd. A (2020–2024)

The table below shows the annual total liabilities of PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥283.73 Million ≈ $41.52 Million	-23.24%
2023-12-31	CN¥369.62 Million ≈ $54.09 Million	+96.21%
2022-12-31	CN¥188.38 Million ≈ $27.57 Million	-10.03%
2021-12-31	CN¥209.37 Million ≈ $30.64 Million	+88.93%
2020-12-31	CN¥110.81 Million ≈ $16.22 Million	--

About PharmaResources (Shanghai) Co. Ltd. A

SHE:301230 China Biotechnology

Market Cap

$845.63 Million

CN¥5.78 Billion CNY

Market Cap Rank

#9881 Global

#2802 in China

Share Price

CN¥41.40

Change (1 day)

-1.31%

52-Week Range

CN¥29.37 - CN¥65.76

All Time High

CN¥65.76